Bishal Gyawali

Queen's University

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Cancer Research Cancer Research professors in Canada

Contact this professor

LinkedIn

Google Scholar

Articles (27)

Cost of Convenience in Cancer Care

Year:

2025

Success in oncology phase 3 trials: a small P value or patient value

Year:

2025

Financial difficulty among patients with cancer participating in clinical trials and its association with patient survival and quality of life

Year:

2025

Inferior control arms in oncology trials in LMICs: contextualised or compromised?

Year:

2025

Treatment Innovations in Pancreatic Cancer: Putting Patient Priorities First

Year:

2025

Analysis of 2023 World Health Organization cancer Essential Medicines List and concordance with resource-stratified guidelines

Year:

2025

Inferior Control Arms in Prostate Cancer Trials: The ARANOTE Trial

Year:

2025

Congruence of cancer screening recommendations between the USPSTF and the top ten US cancer centers: a cross sectional study

Year:

2025

Defining and Measuring Financial Toxicity in Low- and Middle-Income Countries

Year:

2025

Reply to D.J. Stewart et al

Year:

2024

Frequently asked questions on surrogate endpoints in oncology-opportunities, pitfalls, and the way forward

Year:

2024

Geriatric oncology in LMICs: it is time to mature

Year:

2024

Health-related quality of life outcomes reporting associated with FDA approvals in haematology and oncology

Year:

2024

Financial Conflicts of Interest: Payment at the Expense of Patients?

Year:

2024

Breast Cancer-Related Financial Toxicity in Sri Lanka: Insights From a Lower Middle-Income Country With Free Universal Public Healthcare

Year:

2024

The Accelerated Approval Program for Cancer Drugs — Finding the Right Balance

Year:

2023

Cancer Survivorship in the Indo-Pacific: Priorities for Progress

Year:

2023

Could We Have Improved on ADAURA? Refining Global Research Practices to Reduce Cancer Care Disparities

Year:

2023

Comparison of tumor-agnostic and tumor-specific clinical oncology trial designs: a systematic review and meta-analysis

Year:

2023

Problematic crossovers in cancer drug trials

Year:

2023

Evaluating Trials of Adjuvant Therapy: Is There Benefit for People With Resected Renal Cancer?

Year:

2023

Training General Practitioners in Oncology: Lessons Learned From a Cross-Sectional Survey of GPOs in Canada

Year:

2023

Letter to Editor-response: placebo response rates

Year:

2023

Intention to probe into the colonoscopy trial: is it the procedure or the trial that failed?

Year:

2023

Objective response rate of placebo in randomized controlled trials of anticancer medicines

Year:

2023

Progression-Free Survival Should Not Be Used as a Primary End Point for Registration of Anticancer Drugs

Year:

2023

Could We Have Improved on ADAURA? Refining Global Research Practices to Reduce Cancer Care Disparities

Year:

2023

Collaborators (4)

Bogda Koczwara

Flinders University

AUSTRALIA

Alexandre Chan

University of California, Irvine

UNITED STATES

Joseph Ross

Professor

Yale University School of Medicine

UNITED STATES

Ian F. Tannock

-

CANADA

Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI